Subsidiary of Arcplus Group Plc (600629.SH) signed a related engineering design contract worth 56.95 million yuan.

13/11/2024

GMT Eight

Chinastocks APP News, Arcplus Group Plc (600629.SH) announced that its subsidiary, East China Architectural Design & Research Institute Co., Ltd. (hereinafter referred to as "East China Institute"), has signed a contract with the Putuo District Health Committee of Shanghai for the design of the new Western Regional Medical Center (tentative). The contract amount is 56.95 million yuan.

Jiangxi Synergy Pharmaceutical (300636.SZ): The raw material drug of Telmisartan Potassium has been approved by the China Food and Drug Administration (CDE).

Xu Zhengyu: Taking multiple measures to narrow Hong Kong's fiscal deficit, striving for a balanced budget within a few years.

Contact: contact@gmteight.com

Subsidiary of Arcplus Group Plc (600629.SH) signed a related engineering design contract worth 56.95 million yuan.

RECOMMEND

Hunan Jingfeng Pharmaceutical (000908.SZ) has accumulated an increase of 752.78%, and will be halted for verification starting on November 18th.

Anhui Huaertai Chemical (001217.SZ): 189 million restricted shares will be listed for trading on November 21, accounting for 56.8494% of the total share capital.

ZYF Lopsking Material Technology (002333.SZ): Chen Xingcan collectively reduced its holdings by 0.79%, with holdings less than 5%.